RPS6KB1 and breast carcinoma: Since the inhibition of mTORC1 and p70S6K by BEZ235 may activate FOXO, and then accelerate those receptors’ transcription and expression6, we speculated that in breast cancer cells, the upregulation of RTKs induced by BEZ235 may also depend on FOXO activity.